Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

Newsletter Archive

If you would like to receive our newsletters regularly, please click here or send us an email to the following address: info@dr-rath-foundation.org

March 26, 2010

Latest News Updates

Keep up-to-date on the latest health and politics news with our regular updates and analysis of the key stories from around the world.

Natural Health News

March 21, 2010

Study urges vitamin D supplement for infants
Most babies should take a daily vitamin D supplement, a new study shows. That will be a big change for most parents — and even many pediatricians. Only 1% to 13% of infants under 1 year now get a vitamin D supplement, available in inexpensive drops, according to a study published online today in Pediatrics. Those drops are needed, the study says, because only 5% to 37% of American infants met the standard for vitamin D set by the American Academy of Pediatrics in 2008: 400 international units a day. Vitamin D strengthens bone and the immune system and also appears to prevent type 1 diabetes, heart disease and cancer, the paper says.
Read article in USA Today

March 18, 2010

NASA examines omega-3 for bone health during space flight
Supplements of omega-3 EPA (eicosapentaenoic acid) may protect against bone loss during weightlessness, according to a new study from NASA.
Read article at nutraingredients-usa.com
Comment: The researchers say that similar results were observed for people with extended periods of bed-rest and that their data could benefit the general population.

March 18, 2010

Selenium Could Shield Against Diabetes
High levels in men appear to be beneficial, study finds
Scientists have found evidence that older men with higher levels of selenium are less likely to suffer from dysglycemia, or improper blood-sugar metabolism.
Read article at businessweek.com
Comment: To read the abstract for this study, click here.

March 16, 2010

Green tea may boost oral health, reduce tooth loss
Drinking one cup of green tea may improve dental health and reduce the risk of loosing teeth by about 20 per cent, according to a new study from Japan. And drinking more cups appears to confer additional risk reductions, with five or more cups a day associated with a 23 per cent reduction in risk, according to findings from the Ohsaki Cohort 2006 Study published in Preventive Medicine.
Read article at foodnavigator.com
Comment: Additional research suggests that Green tea may block lung cancer; reduce the risk of death from colorectal cancer and heart disease; protect against blood cell cancer; protect against breast cancer; halve the risks of developing advanced prostate cancer and combat depression. Similarly, research has also shown that supplements containing extracts of green tea can inhibit the human immunodeficiency virus (HIV); treat leukaemia; prevent oral cancer; reduce levels of compounds linked to prostate cancer progression; lower blood pressure and boost blood vessel health. To read about Dr. Rath’s research showing how a nutrient combination - including the green tea extract Epigallocatechin Gallate (EGCG), vitamin C, L-lysine and L-proline - works synergistically to stop the spread of cancer cells through connective tissue, click here.

For more natural health news, click here.

See also our 2001-2009 news archive, by clicking here.

Pharma "Business with Disease" News

March 23, 2010

Va. seeks to join lawsuit over prescription drug
Virginia wants to join a federal lawsuit claiming that health care giant Johnson & Johnson paid tens of millions of dollars in kickbacks so nursing homes would put patients on its schizophrenia drug.
Read article at newsleader.com (USA)

March 19, 2010

FDA Warns About Zocor And Muscle Damage
Yet another problem for Merck. The agency says there’s a potential for increased risk of muscle injury from the 80 mg dose of Zocor, or simvastatin, as the generic is known. In issuing its warning, the FDA notes muscle injury, or myopathy, is a known side effect with all statins, but this new concern highlights “the greater risk of developing muscle injury, including rhabdomyolysis” while on the highest dose. Rhabdomyolysis is the most serious form of myopathy and can lead to severe kidney damage, kidney failure, and sometimes death.
Read article at pharmalot.com
Comment: Cholesterol-lowering drugs are the single largest business segment of the global pharmaceutical drug business. The global sales of the leading drug category – statins – have surpassed 200 billion dollars per year. This entire business is built on fear – the fear that cholesterol actually causes heart attacks. While this “cholesterol-scare” has become a gold mine for the drug companies – the economic burden of this business is ultimately carried by us, the people. Health professionals, political decision takers and hundreds of millions of patients worldwide have the right to know: What are the proven facts – and what is the fiction promoted by the multi-billion dollar investment business with patented cholesterol-lowering drugs. To learn the truth about cholesterol drugs, click here.

March 18, 2010

New attack on EU plans for patient drug information
The European Commission has been told that the “only rationale” for its current plans to ease certain controls on the provision of prescription drug information to the public “seems to be to benefit the commercial interests of pharmaceutical companies by expanding their markets and helping them to build brand loyalty.” The long-delayed proposals do not meet citizens’ needs and would expose them to “intensive promotion” of new drugs, claims a statement issued this week by 29 European organisations representing patient groups, social insurance bodies, physicians and others, coordinated by the European Public Health Alliance (EPHA).
Read article at pharmatimes.com (UK)

March 18, 2010

Diabetes Drug Supporters Had Financial Tie to Glaxo, Study Says
Most scientists who published articles supporting GlaxoSmithKline Plc’s diabetes drug Avandia after it was linked to heart disease in 2007 had financial ties to the company, according to a Mayo Clinic report. The Mayo researchers examined more than 200 articles that appeared after an analysis in the New England Journal of Medicine linked Avandia to a 43 percent increased risk of heart attacks, and a subsequent clinical trial found no greater danger of heart disease. Almost 90 percent of scientists who wrote positive articles, reviews or commentaries about Avandia had financial ties to London-based Glaxo, the study published in the British Medical Journal found.
Read article at businessweek.com

For more pharma "business with disease" news, click here.

See also our 2001-2009 news archive, by clicking here.

GMO News

March 22, 2010

Anti GMO demonstration outside the Polish Parliament
On the afternoon of March 17, ICPPC (International Coalition to protect the Polish countryside) and the Coalition for a GMO Free Poland staged an anti GMO demonstration outside the Polish Parliament. At the demonstration, people were dressed in dark hooded cloaks and stood in a line, reading short excerpts from books exposing the truth behind GMO. In the background Gorale - mountain farmers - sang an anti GMO adaptation of the resistance song "We Shall Not Be Moved" while demonstrators displayed their “No to GMO“ banners and bee keepers lit their smoke guns and donned their overalls. The TV crews rolled their film. The GMO Act which the government was threatening to introduce has not made it to the statute books, after overwhelming opposition halted it. Instead, the government has convened another committee to try to work out some kind of resolution to the state of impasse. This represents a temporary victory.
Read article at organic-market.info

March 20, 2010

Colonialism lives in biotech seed proposal for Africa
Bill Gates and the biotech juggernauts are doing their best to keep Africa dependent on imported technology, just like in the bad old days of colonialism. Gates, Monsanto and Pioneer have joined the long list of those believing they know best how the continent should grow its food. If the history of colonialism and subsequent development practice have taught us anything, it is that all interventions must strengthen resilience, encourage diversity and be locally appropriate. The biotech seed proposal for Africa fails on all three counts.
Read article in the Des Moines Register (Iowa/USA)
Comment: The brutal colonialism of previous decades has been replaced in Africa by more subtle forms of suppression, including the biotech seed proposal. Another example of modern-day colonialism, and arguably the most deadly of all, is that of pharmaceutical colonialism. Under the mask of a “Mother Theresa”, pharmaceutical multinationals are using the developing world as a testing ground and multi-billion market place for toxic and often deadly drugs. To learn more, click here.

March 19, 2010

Bulgaria approves law to ban GMO crops
Bulgaria's parliament voted on Thursday (18 March) to tighten a law that effectively banned cultivation of genetically-modified (GM) crops for scientific and commercial reasons in response to public fears.
Read article at euractiv.com

March 18, 2010

Bolivia Challenges Patentability of Life Forms
Bolivia has challenged, during the World Trade Organization (WTO) negotiations of the Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS), the prevailing philosophy of the patentability of life forms.
Read article at laleva.org (Italy)

March 16, 2010

Eli Lilly's Desperate, Deceptive Campaign to Boost Bovine Growth Hormone
With sales and public perception of bovine growth hormone dropping fast in the U.S., it’s not easy to find reputable scientific organizations willing to endorse such a controversial genetically modified additive. So, in a shameless and desperate maneuver, Eli Lilly decided to make some up.
Read article at bnet.com

March 6, 2010

Bt cotton ineffective against pest in parts of Gujarat, admits Monsanto
NEW DELHI: For the first time anywhere in the world, biotech agriculture giant Monsanto has admitted that insects have developed resistance to its Bt cotton crop. Field monitoring in parts of Gujarat has discovered that the Bt crop is no longer effective against the pink bollworm pest there. The company is advocating that Indian farmers switch to its second-generation product to delay resistance further. Monsanto's critics say that this just proves the ineffectiveness of the Bt technology, which was recently sought to be introduced in India in Bt brinjal as well.
Read article in The Hindu (India)

February 19, 2010

Crop Scientists Say Biotechnology Seed Companies Are Thwarting Research
Biotechnology companies are keeping university scientists from fully researching the effectiveness and environmental impact of the industry’s genetically modified crops, according to an unusual complaint issued by a group of those scientists. “No truly independent research can be legally conducted on many critical questions,” the scientists wrote in a statement submitted to the Environmental Protection Agency. The E.P.A. is seeking public comments for scientific meetings it will hold next week on biotech crops. The statement will probably give support to critics of biotech crops, like environmental groups, who have long complained that the crops have not been studied thoroughly enough and could have unintended health and environmental consequences.
Read article in the New York Times (USA)

For more GMO news, click here.

See also our 2001-2009 news archive, by clicking here.

Other Health-related News

March 23, 2010

EU urged to help tackle Vitamin D deficiency
A parliamentary hearing has been told the EU should adopt an "effective and efficient" strategy to tackle the growing problem of vitamin D deficiency. The workshop on Tuesday heard there is currently a "huge" shortfall in Europe in the recommended intake of vitamin D.
Read article at theparliament.com

March 19, 2010

EU meddling with health food stores puts 4,000 jobs at risk
New curbs on vitamin and mineral pills by Brussels are threatening to push hundreds of UK health food stores out of business with the loss of up to 4,000 jobs. Campaigners say the EU Commission’s plans will hit hundreds of their best-selling supplements, including vitamins A, C, and D, folic acid, calcium and iron.
Read article in the Daily Express (UK)
Comment: The “government” of the Brussels EU – the unelected EU Commission – is soon expected to be making an announcement on proposed new maximum permitted levels for vitamins and minerals in food supplements. If you live in the EU, click here to visit the website of the European Referendum Initiative and sign the petition for a referendum on natural remedies, which aims to guarantee free access to scientifically based natural health remedies for all EU citizens via the holding of a referendum in all 27 EU Member States.

March 18, 2010

Nutrition training for doctors 'must be improved'
Nutrition needs to be made a more important part of the doctor training system, a leading expert has said. Gastroenterologist Dr Penny Neild, who works at London's St George's Hospital, said training on how to spot and tackle malnutrition was "patchy". She said medical schools and junior doctor programmes were focusing too much on the science of being a doctor rather than basic care.
Read article on the BBC News website (UK)

March 17, 2010

The latest news on the S.510 and S.3002 attacks on health
There is much confusion and debate swirling around the pending, or near-pending, demise of Senator McCain’s so-called “Dietary Supplement Safety Act of 2010 (S.3002). After Senators John McCain (R-AZ) and Byron Dorgan (D-ND) issued their letter of March 10th, what is clear about the bill’s status is the following: 1. S.3002 will wither on the vine in the Senate. 2. Instead, when the so-called Food Safety Act (S.510) is brought up again in the Senate, there may be a McCain-Dorgan amendment offered to it, which Senators Hatch and Harkin will have to review first. 3. This amendment could be accepted and added by unanimous consent before S.510 is voted upon. 4. If it passes the Senate, then the House and Senate leadership would work out any differences and pass it on to Mr. Obama. The best estimates are that this would not happen until after Congress returns in mid-April 2010. 5. As of today, S.510 is still on the Senate calendar and not scheduled for a vote.
Read press release on the website of the National Health Federation (NHF) (USA)

March 17, 2010

Study: Low levels of vitamin D linked to higher rates of asthma in African-American kids
Researchers at Children's National Medical Center have discovered that African American children with asthma in metropolitan Washington, DC, are significantly more likely to have low levels of vitamin D than healthy African American children.
Read article at physorg.com

For more health-related news, click here.

See also our 2001-2009 news archive, by clicking here.

Political News

March 23, 2010

Buzek suggests electing EU commissioners
Jerzy Buzek, the Polish president of the European Parliament, has suggested that future EU commissioners should compete in Europe-wide elections to get a "democratic mandate".
Read article at euractiv.com
Comment: All modern democracies around the world have one principle in common: their power derives from the people. However, this is not so with the “Brussels EU”. The “government” of this construct – the 27-member EU Commission – is appointed on behalf of corporate interests. No man or woman in Europe today has the right to vote for it or to terminate its rule. As such, the “Brussels EU” is undeniably a dictatorship. To learn the facts about the “Brussels EU”, click here.

March 18, 2010

EU firms 'exporting torture equipment', Amnesty says
Euro MPs have heard claims that EU companies are exporting equipment used for torture despite legislation aimed at preventing such trade. Amnesty International has published a report detailing the claims, and was briefing the European Parliament's Sub-Committee on Human Rights. The equipment includes thumb-cuffs and devices that give electric shocks. Amnesty said firms from Germany, the Czech Republic, Spain and Italy were among those trading the items.
Read article on the BBC News website (UK)

For more political news, visit the news pages on the website of the International Alliance for Health, Peace and Social Justice, and the news page on the European Referendum Initiative website.

Back to the Newsletter Archive…